63
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Psychotropic Medication from an Object Relations Theory Perspective: An Analysis of Vignettes from Group Psychotherapy

, M.A., , Psy.D., , M.D. & , M.D.
Pages 303-326 | Received 28 Nov 2006, Accepted 30 Jul 2007, Published online: 26 Aug 2015
 

Abstract

In this article we explore the content and dynamics of patients’ verbalizations within a “living with medications” group. Patients’ perceptions of their psychotropic medications are interpreted and classified within the framework of object relations theory. One’s perception of the role of medication in one’s life can serve as a gateway to one’s inner world and the way that he or she perceives authority figures, peers, and oneself. We suggest that working through patients’ relationships with their medications can help them to achieve better integration of internal object relations. Discussing patients’ views about medications should therefore be seen as an important part of psychotherapy with many individuals. Such a discussion may enhance and improve efficacy of both psychotherapy and pharmacotherapy. It is of particular importance in group therapy, within milieu environments and with individuals reluctant to explicitly discuss interpersonal matters. Vignettes from the group sessions illustrate the way in which discussing medication advances group process.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.